Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury

Critical Care Medicine

Volumn 38, Issue 4, 2010, Pages 1179-1186

  Perl, Mario ^c   Chung, Chun Shiang ^a,b   Perl, Ulrike ^a,b   Thakkar, Rajan ^a,b   Lomas Neira, Joanne ^a,b   Ayala, Alfred ^a,b  

^a Department of Surgery   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Acute respiratory distress syndrome; Apoptosis; Gene silencing; Hemorrhagic shock; Sepsis; Small interfering RNA

Indexed keywords

CASPASE 3; CHEMOKINE; CYTOKINE; EPITOPE; MYELOPEROXIDASE; SMALL INTERFERING RNA;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; EPITHELIUM CELL; GENE SILENCING; HEMORRHAGIC SHOCK; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; MALE; MORBIDITY; MORTALITY; MOUSE; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RNA SEQUENCE; SEPSIS; SURVIVAL; WESTERN BLOTTING;

EID: 77950199822     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181d4563f     Document Type: Article

References (41)

1. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693
2. Wheeler AP, Bernard GR: Acute lung injury and the acute respiratory distress syndrome: A clinical review. Lancet 2007; 369: 1553-1564
3. Herridge MS, Angus DC: Acute lung injury\ affecting many lives. N Engl J Med 2005; 353:1736-1738
4. Brun-Buisson C, Minelli C, Bertolini G, et al: Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 2004; 30:51-61
5. Goss CH, Brower RG, Hudson LD, et al: Incidence of acute lung injury in the United States. Crit Care Med 2003; 31:1607-1611
6. Shah CV, Localio AR, Lanken PN, et al: The impact of development of acute lung injury on hospital mortality in critically ill trauma patients. Crit Care Med 2008; 36:2309-2315
7. Vincent JL, Zambon M: Why do patients who have acute lung injury/acute respiratory distress syndrome die from multiple organ dysfunction syndrome? Implications for management. Clin Chest Med 2006; 27:725-731
8. Monchi M, Bellenfant F, Cariou A, et al: Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 1998; 158:1076-1081
9. ARDS Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301-1308
10. Perl M, Chung CS, Ayala A: Apoptosis. Crit Care Med 2005; 33:S526-S529
11. Perl M, Chung CS, Lomas-Neira J, et al: Silencing of fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apo-ptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am J Pathol 2005; 167:1545-1559
12. Perl M, Chung CS, Perl U, et al: Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Respir Crit Care Med 2007; 176:591-601
13. Perl M, Lomas-Neira J, Chung CS, et al: Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs. Mol Med 2008; 14: 465-475
14. Novina CD, Murray MF, Dykxhoorn DM, et al: siRNA-directed inhibition of HIV-1 infection. Nat Med 2002; 8:681-686
15. Ayala A, Chung CS, Lomas JL, et al: Shock-induced neutrophil mediated priming for acute lung injury in mice: Divergent effects of TLR-4 and TLR-4/FasL deficiency. Am J Pathol 2002; 161:2283-2294
16. Leers MP, Kolgen W, Bjorklund V, et al: Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 1999; 187: 567-572
17. Bachofen M, Weibel ER: Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982; 3:35-56
18. Bardales RH, Xie SS, Schaefer RF, et al: Ap-optosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 1996; 149: 845-852
19. Bem RA, Bos AP, Matute-Bello G, et al: Lung epithelial cell apoptosis during acute lung injury in infancy. Pediatr Crit Care Med 2007; 8:132-137
20. Guinee D Jr, Brambilla E, Fleming M, et al: The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am J Pathol 1997; 151:999-1007
21. Albertine KH, Soulier MF, Wang Z, et al: Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 2002; 161: 1783-1796
22. Lee KS, Choi YH, Kim YS, et al: Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Respir Med 2008; 102:464-469
23. Hashimoto S, Kobayashi A, Kooguchi K, et al: Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161:237-243
24. Matute-Bello G, Liles WC, Steinberg KP, et al: Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 1999; 163:2217-2225
25. Kitamura Y, Hashimoto S, Mizuta N, et al: Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med 2001; 163:762-769
26. Matute-Bello G, Frevert CW, Liles WC, et al: Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect Immun 2001; 69:5768-5776
27. Tateda K, Deng JC, Moore TA, et al: Hyper-oxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J Immunol 2003; 170:4209-4216
28. Lomas-Neira JL, Chung CS, Wesche DE, et al: In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J Leukoc Biol 2005; 77: 846-853
29. Zhang X, Shan P, Jiang D, et al: Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 2004; 279: 10677-10684
30. Tanaka T, Yoshimi M, Maeyama T, et al: Resistance to Fas-mediated apoptosis in human lung fibroblast. Eur Respir J 2002; 20: 359-368
31. Sun L, Guo RF, Gao H, et al: Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells. FASEB J 2009; 23: 3807-3818
32. Whitehead KA, Langer R, Anderson DG: Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009; 8:129-138
33. Kataoka T, Budd RC, Holler N, et al: The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 2000; 10:640-648
34. Faouzi S, Burckhardt BE, Hanson JC, et al: Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001; 276:49077-49082
35. Daemen MA, van 't Veer C, Denecker G, et al: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 1999; 104:541-549
36. Kuwano K, Kunitake R, Maeyama T, et al: Attenuation of bleomycin-induced pneumo-pathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2001; 280: L316-L325
37. Bem RA, Farnand AW, Wong V, et al: Depletion of resident alveolar macrophages does not prevent Fas-mediated lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2008; 295:L314-L325
38. de FA, Vornlocher HP, Maraganore J, et al: Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Dis-cov 2007; 6:443-453
39. Thomas M, Lu JJ, Ge Q, et al: Full deacyla-tion of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci USA 2005; 102:5679-5684
40. Akhtar S, Benter IF: Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest 2007; 117:3623-3632
41. Thomas M, Lu JJ, Chen J, et al: Non-viral siRNA delivery to the lung. Adv Drug Deliv Rev 2007; 59:124-133